MondegarAI
Monashee Investment Management LLC

Q1 2026 · 13F-HR

Monashee Investment Management LLCholdings as filed

Filed 2026-05-13 · accession 0001172661-26-001803

$183.8M
Reported value
45
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · Monashee Investment Management LLC · Q1 2026

AI · grounded in 13F

Monashee Investment Management LLC initiated a new position in NEXTERA ENERGY INC [[stock:NEE 7.375 02/15/29]] valued at $15.2M. The fund also established new stakes in NRG ENERGY INC NRG for $12.4M and FORGENT POWER SOLUTIONS INC FPS for $10.2M. On the sell side, the fund closed its positions in SOFI TECHNOLOGIES INC SOFI and UL SOLUTIONS INC ULS, reducing exposure by $10.5M and $10.3M respectively.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
880881107430TERNS PHARMACEUTICALS INC$15.8M8.60%300,000CommonSOLE
65339F655NEE 7.375 02/15/29NEXTERA ENERGY INC$15.2M8.28%299,970CommonSOLE
58507V107MDLNMEDLINE INC$13.3M7.26%300,000CommonSOLE
629377508NRGNRG ENERGY INC$12.4M6.76%85,000CommonSOLE
34631F102FPSFORGENT POWER SOLUTIONS INC$10.2M5.57%350,000CommonSOLE
83422E204SLDBSOLID BIOSCIENCES INC$10.2M5.56%1,420,295CommonSOLE
640268306NKTRNEKTAR THERAPEUTICS$7.2M3.91%100,000CommonSOLE
23282W605CYTKCYTOKINETICS INC$6.6M3.59%100,000CommonSOLE
47775AAA9JOBY 0.75 02/15/32JOBY AVIATION INC$5.9M3.19%7,000,000CommonSOLE
69351T866PPL 7 02/15/29PPL CORP$5.2M2.85%101,300CommonSOLE
10806X102BBIOBRIDGEBIO PHARMA INC$5.0M2.71%67,139CommonSOLE
00090Q103ADTADT INC DEL$4.6M2.50%700,000CommonSOLE
68389X204ORCL 6.5 01/15/29 DORACLE CORP$4.5M2.45%100,000CommonSOLE
30054Y107EVMNEVOMMUNE INC$4.1M2.24%179,340CommonSOLE
48251W500KKR 6.25 03/01/28 DKKR & CO INC$4.0M2.19%100,000CommonSOLE
00217D100ASTSAST SPACEMOBILE INC$3.7M2.03%45,000CommonSOLE
98937LAA3ZBIO 2.5 04/01/32ZENAS BIOPHARMA INC$3.2M1.75%3,152,000CommonSOLE
80004C200SNDKSANDISK CORP$3.2M1.73%5,000CommonSOLE
922967104MANEVERADERMICS INC$3.2M1.72%50,000CommonSOLE
98937L105ZBIOZENAS BIOPHARMA INC$2.9M1.60%150,000CommonSOLE
501575104KYMRKYMERA THERAPEUTICS INC$2.9M1.59%35,100CommonSOLE
023193105AMBQAMBIQ MICRO INC$2.6M1.43%103,756CommonSOLE
60365F109MMEDMINIMED GROUP INC$2.6M1.42%175,000CommonSOLE
349381103FIGRFIGURE TECHNOLOGY SOLUTIO$2.6M1.41%76,520CommonSOLE
85220G109SGPSPYGLASS PHARMA INC$2.5M1.34%95,000CommonSOLE
86366E106GPCRSTRUCTURE THERAPEUTICS INC$2.4M1.31%50,000CommonSOLE
H17182108CRSPCRISPR THERAPEUTICS AG$2.4M1.29%50,000CommonSOLE
457152106INGMINGRAM MICRO HLDG CORP$2.3M1.27%100,000CommonSOLE
G39387108GFSGLOBALFOUNDRIES INC$2.2M1.21%50,000CommonSOLE
29286M105ENGENE HOLDINGS INC$2.2M1.19%320,000CommonSOLE
342909108FLOCFLOWCO HLDGS INC$2.1M1.12%100,000CommonSOLE
78397T202SABSSAB BIOTHERAPEUTICS INC$1.9M1.04%500,000CommonSOLE
00461U105ACRSACLARIS THERAPEUTICS INC$1.9M1.02%500,000CommonSOLE
40609P105HNRGHALLADOR ENERGY COMPANY$1.5M0.80%90,000CommonSOLE
Y62132108NVGSNAVIGATOR HLDGS LTD$1.4M0.79%75,000CommonSOLE
G4444S107HLXCHELIX ACQUISITION CORP III$1.4M0.76%137,113CommonSOLE
20454B104CMPXCOMPASS THERAPEUTICS INC$1.4M0.74%258,865CommonSOLE
091947101BTGOBITGO HOLDINGS INC$1.2M0.67%150,000CommonSOLE
19247G107COHRCOHERENT CORP$1.2M0.65%5,000CommonSOLE
471024109JANJANUS LIVING INC$1.2M0.64%50,000CommonSOLE
G96115103WYFIWHITEFIBER INC$952,8000.52%80,000CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$896,0000.49%100,000CommonSOLE
38341PAA0GOSS 5 06/01/27GOSSAMER BIO INC$845,2820.46%2,167,000CommonSOLE
29280W109NRGVENERGY VAULT HOLDINGS INC$582,2950.32%176,453CommonSOLE
80401L803MSLESATELLOS BIOSCIENCE INC$67,5600.04%12,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.